Despite the availability of potent antibiotics, bacterial meningitis is still a major clinical problem. Mortality is high, and up to a third of survivors are left with neurologic sequelae that may range from mild behavioral disorders to mental retardation or deafness. New therapeutic approaches to meningeal inflammation, however, are reducing the neurologic risks.
|Original language||English (US)|
|Number of pages||10|
|State||Published - Jan 1 1991|
ASJC Scopus subject areas